Why are Higher CD34+ Cell Doses Associated with Improved Outcomes among Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors – But Not for High-Risk Neuroblastoma? - Knight, Tristan E.; Broglie, Larisa; Sharma, Akshay; Qayed, Muna; Yanik, Gregory A. (Pediatric Hematology & Oncology, 2025)